ArticleScientific reports2017

Intravenous Formulation of HET0016 Decreased Human Glioblastoma Growth and Implicated Survival Benefit in Rat Xenograft Models.

Meenu Jain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.